comparemela.com

Page 46 - ரோச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IQVIA announces growth in customer engagement solution

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90. IQVIA has announced its Orchestrated Customer Engagement (OCE) solution is now in use by 140 life-sciences companies located in 90 countries. The most recent to sign on, Laboratoires Thea, is an independent eye-care group in Europe. The company reports its clients are leveraging OCE to accelerate their global digital transformation, in order to lead to more impactful interactions with customers. Customers now include AstraZeneca, Novo Nordisk, Roche, Adhera Therapeutics, Napo Pharmaceuticals, Pierre Fabre Pharmaceuticals, PruGen Pharmaceuticals, Recordati, Theramex and Zentiva. Susan Hill, vice president and general manager of customer engagement with IQVIA, told Outsourcing-Pharma that the COVID-19 pandemic has created a need for accelerated digital adoption in pharma development firms.

Press Release: Roche signs definitive merger agreement with GenMark Diagnostics, Inc , to access novel technology to test for broad range of pathogens with one patient sample

Press Release: Roche signs definitive merger agreement with GenMark Diagnostics, Inc , to access novel technology to test for broad range of pathogens with one patient sample
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Roche To Buy Covid Test Maker GenMark Diagnostics For $1 8 Bn

Roche to acquire GenMark Diagnostics for $1 8 B

Corbus Pharmaceuticals Holdings, Inc (CRBP) Q4 2020 Earnings Call Transcript

Hello, and welcome to the Corbus Pharmaceuticals Fourth Quarter and Year-End 2020 Earnings Conference Call. [Operator Instructions] Note that this conference call is being recorded at the Company s request and will be made available on the Company s website following the end of the call. I would now like to turn the conference over to your host, Ted Jenkins, Senior Director, Investor Relations and Corporate Communications. Please go ahead, sir. Ted Jenkins Thank you, operator, and good morning everyone. Thank you for joining us today. At this time, I d like to remind our listeners that remarks made during this call may state management s intentions, hopes, beliefs, expectations or future projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws. These forward-looking statements are based on Corbus current expectations and actual

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.